217 filings
Page 2 of 11
6-K
kcwk e2g8y
17 Oct 23
Current report (foreign)
7:01am
6-K
p0ftxaall13g9i1bi2g
20 Sep 23
Current report (foreign)
4:03pm
6-K
8nqgs8a
7 Sep 23
Current report (foreign)
7:37am
6-K
nuw78sg6sey
6 Jul 23
Ultragenyx Announces First Patients Dosed in Phase 3 Program
8:05am
6-K
flti44owpc
30 Jun 23
Current report (foreign)
4:05pm
6-K
imykte3
7 Jun 23
Current report (foreign)
8:41am
6-K
t3fi77
5 Jun 23
Ultragenyx and Mereo BioPharma Announce Positive Data from the Ongoing Phase 2/3 Orbit
4:37pm
6-K
859vs25r6nxvgpx9
22 May 23
Current report (foreign)
4:15pm
6-K
95s z29elnd
8 May 23
Current report (foreign)
4:07pm
6-K
qrqu j2opdi
5 May 23
Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
5:06pm
6-K
06z6q
27 Apr 23
Current report (foreign)
4:15pm
6-K
yxlhc5x 88c
12 Apr 23
Current report (foreign)
4:01pm
6-K
7wvyo8mc
28 Mar 23
Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlights
4:37pm
6-K
a5qgasmkc8r
21 Mar 23
Current report (foreign)
6:48am
S-8
336w 1p0s
24 Jan 23
Registration of securities for employees
4:32pm
6-K
4wlbqyyrw ctdbd
10 Nov 22
Current report (foreign)
4:10pm
6-K
sccj9pdwat6n9
10 Nov 22
Current report (foreign)
4:06pm
6-K
s9yg3uxtpwqyjfx9bh
2 Nov 22
Current report (foreign)
4:17pm
6-K
a9u0 9anamm8eno
2 Nov 22
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency
4:07pm